Australia Says Tamiflu Use To Remain Restricted For H1N1
This article was originally published in PharmAsia News
Executive Summary
Australia's health minister cautioned the public against using Roche's Tamiflu (oseltamivir) for the H1N1 influenza virus now declared a global pandemic. Health Minister Nicola Roxon said the drug would not be prescribed for most cases of the swine flu, particularly not for mild cases. High demand already is restricting commercial supplies, she said, but the government still has stockpiles of the drug available. She also said the World Health Organization declaration of a pandemic would not necessarily change Australia's handling of H1N1. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.